InVivo Therapeutics Holdings Corp. NVIV
$ 0.31
-37.48%
Quarterly report 2023-Q3
added 11-08-2023
Country |
USA |
IPO year |
- |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ CAPITAL |
CEO |
Dr. Richard Toselli |
Employees in the company |
6 |
Shares |
1.54 M |
Market Cap[1] |
$ 476 K |
EBITDA (LTM) |
$ -10.2 M |
P/E (LTM) |
-0.2 |
P/S (LTM) |
- |
EPS (LTM) |
-4.32 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.